BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

677 related articles for article (PubMed ID: 21923922)

  • 1. Mammary gland specific expression of Brk/PTK6 promotes delayed involution and tumor formation associated with activation of p38 MAPK.
    Lofgren KA; Ostrander JH; Housa D; Hubbard GK; Locatelli A; Bliss RL; Schwertfeger KL; Lange CA
    Breast Cancer Res; 2011 Sep; 13(5):R89. PubMed ID: 21923922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein tyrosine kinase 6 promotes ERBB2-induced mammary gland tumorigenesis in the mouse.
    Peng M; Ball-Kell SM; Tyner AL
    Cell Death Dis; 2015 Aug; 6(8):e1848. PubMed ID: 26247733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted expression of activated Rac3 in mammary epithelium leads to defective postlactational involution and benign mammary gland lesions.
    Leung K; Nagy A; Gonzalez-Gomez I; Groffen J; Heisterkamp N; Kaartinen V
    Cells Tissues Organs; 2003; 175(2):72-83. PubMed ID: 14605486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast tumor kinase and extracellular signal-regulated kinase 5 mediate Met receptor signaling to cell migration in breast cancer cells.
    Castro NE; Lange CA
    Breast Cancer Res; 2010; 12(4):R60. PubMed ID: 20687930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast tumor kinase (protein tyrosine kinase 6) regulates heregulin-induced activation of ERK5 and p38 MAP kinases in breast cancer cells.
    Ostrander JH; Daniel AR; Lofgren K; Kleer CG; Lange CA
    Cancer Res; 2007 May; 67(9):4199-209. PubMed ID: 17483331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast tumor kinase (Brk/PTK6) is a mediator of hypoxia-associated breast cancer progression.
    Regan Anderson TM; Peacock DL; Daniel AR; Hubbard GK; Lofgren KA; Girard BJ; Schörg A; Hoogewijs D; Wenger RH; Seagroves TN; Lange CA
    Cancer Res; 2013 Sep; 73(18):5810-20. PubMed ID: 23928995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of human Cripto-1 in transgenic mice delays mammary gland development and differentiation and induces mammary tumorigenesis.
    Sun Y; Strizzi L; Raafat A; Hirota M; Bianco C; Feigenbaum L; Kenney N; Wechselberger C; Callahan R; Salomon DS
    Am J Pathol; 2005 Aug; 167(2):585-97. PubMed ID: 16049342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brk/PTK6 cooperates with HER2 and Src in regulating breast cancer cell survival and epithelial-to-mesenchymal transition.
    Ai M; Liang K; Lu Y; Qiu S; Fan Z
    Cancer Biol Ther; 2013 Mar; 14(3):237-45. PubMed ID: 23291984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of protein tyrosine kinase 6 (PTK6) on human epidermal growth factor receptor (HER) signalling in breast cancer.
    Ludyga N; Anastasov N; Gonzalez-Vasconcellos I; Ram M; Höfler H; Aubele M
    Mol Biosyst; 2011 May; 7(5):1603-12. PubMed ID: 21380407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis.
    Cabodi S; Tinnirello A; Di Stefano P; Bisarò B; Ambrosino E; Castellano I; Sapino A; Arisio R; Cavallo F; Forni G; Glukhova M; Silengo L; Altruda F; Turco E; Tarone G; Defilippi P
    Cancer Res; 2006 May; 66(9):4672-80. PubMed ID: 16651418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PTK6 inhibition promotes apoptosis of Lapatinib-resistant Her2(+) breast cancer cells by inducing Bim.
    Park SH; Ito K; Olcott W; Katsyv I; Halstead-Nussloch G; Irie HY
    Breast Cancer Res; 2015 Jun; 17(1):86. PubMed ID: 26084280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PTK6/BRK is expressed in the normal mammary gland and activated at the plasma membrane in breast tumors.
    Peng M; Emmadi R; Wang Z; Wiley EL; Gann PH; Khan SA; Banerji N; McDonald W; Asztalos S; Pham TN; Tonetti DA; Tyner AL
    Oncotarget; 2014 Aug; 5(15):6038-48. PubMed ID: 25153721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disruption of the mouse protein tyrosine kinase 6 gene prevents STAT3 activation and confers resistance to azoxymethane.
    Gierut J; Zheng Y; Bie W; Carroll RE; Ball-Kell S; Haegebarth A; Tyner AL
    Gastroenterology; 2011 Oct; 141(4):1371-80, 1380.e1-2. PubMed ID: 21741923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p63 is a prosurvival factor in the adult mammary gland during post-lactational involution, affecting PI-MECs and ErbB2 tumorigenesis.
    Yallowitz AR; Alexandrova EM; Talos F; Xu S; Marchenko ND; Moll UM
    Cell Death Differ; 2014 Apr; 21(4):645-54. PubMed ID: 24440910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cdc42 overexpression induces hyperbranching in the developing mammary gland by enhancing cell migration.
    Bray K; Gillette M; Young J; Loughran E; Hwang M; Sears JC; Vargo-Gogola T
    Breast Cancer Res; 2013; 15(5):R91. PubMed ID: 24074261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Taxol Induces Brk-dependent Prosurvival Phenotypes in TNBC Cells through an AhR/GR/HIF-driven Signaling Axis.
    Regan Anderson TM; Ma S; Perez Kerkvliet C; Peng Y; Helle TM; Krutilina RI; Raj GV; Cidlowski JA; Ostrander JH; Schwertfeger KL; Seagroves TN; Lange CA
    Mol Cancer Res; 2018 Nov; 16(11):1761-1772. PubMed ID: 29991529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BRK targets Dok1 for ubiquitin-mediated proteasomal degradation to promote cell proliferation and migration.
    Miah S; Goel RK; Dai C; Kalra N; Beaton-Brown E; Bagu ET; Bonham K; Lukong KE
    PLoS One; 2014; 9(2):e87684. PubMed ID: 24523872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of Cripto-1 signaling and biological activity by caveolin-1 in mammary epithelial cells.
    Bianco C; Strizzi L; Mancino M; Watanabe K; Gonzales M; Hamada S; Raafat A; Sahlah L; Chang C; Sotgia F; Normanno N; Lisanti M; Salomon DS
    Am J Pathol; 2008 Feb; 172(2):345-57. PubMed ID: 18202186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Src phosphorylates Tyr284 in TGF-beta type II receptor and regulates TGF-beta stimulation of p38 MAPK during breast cancer cell proliferation and invasion.
    Galliher AJ; Schiemann WP
    Cancer Res; 2007 Apr; 67(8):3752-8. PubMed ID: 17440088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein tyrosine kinase 6 protects cells from anoikis by directly phosphorylating focal adhesion kinase and activating AKT.
    Zheng Y; Gierut J; Wang Z; Miao J; Asara JM; Tyner AL
    Oncogene; 2013 Sep; 32(36):4304-12. PubMed ID: 23027128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.